神奇的app
居然能无限的网络连接请重试！！！！！！！！！！！！！改一下这个bug吧！
中慈助医多吉美
Published by:
北京医方科技有限公司
Description
中慈助医应用以中华慈善总会多吉美慈善援助项目的业务流程出发，按照患者、医生两套独立使用场景，借助人性化的“一键式”操作界面，直观、简洁地呈现项目流程中的各项操作环节，通过移动互联技术，实现病理报告、医学资料及小视频影像上传，让入组患者与注册医生之间轻松实现远程医学随访，有效减少了传统大病随访为患者及家属带来的种种不便，以高效的随访效率，让患者更为便捷地领取到免费援助药品，有效改善我国大病肿瘤领域患者“随访难、领药难”的现状。
本应用兼容文字发布及拍照上传的线上客服功能，能够有效延展电话客服仅靠语音的唯一服务模式，以更直观、更精确的服务方式，主动为入组患者（及潜在入组患者）解决流程疑问，提升患者项目申请材料、医学随访材料填报的精准度和通过率。
中慈助医应用以我国大病肿瘤（肝癌、肾癌）患者申请慈善援助项目的核心诉求出发，有效改善项目申请、医学随访，领取援助药品等环节上的体验度。
Hide
Show More...
本应用兼容文字发布及拍照上传的线上客服功能，能够有效延展电话客服仅靠语音的唯一服务模式，以更直观、更精确的服务方式，主动为入组患者（及潜在入组患者）解决流程疑问，提升患者项目申请材料、医学随访材料填报的精准度和通过率。
中慈助医应用以我国大病肿瘤（肝癌、肾癌）患者申请慈善援助项目的核心诉求出发，有效改善项目申请、医学随访，领取援助药品等环节上的体验度。
Screenshots
中慈助医多吉美 FAQ
-
Is 中慈助医多吉美 free?
Yes, 中慈助医多吉美 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 中慈助医多吉美 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 中慈助医多吉美 cost?
中慈助医多吉美 is free.
-
What is 中慈助医多吉美 revenue?
To get estimated revenue of 中慈助医多吉美 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Lebanon yet.
Ratings History
中慈助医多吉美 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
中慈助医多吉美 Installs
Last 30 days
中慈助医多吉美 Revenue
Last 30 days中慈助医多吉美 Revenue and Downloads
Gain valuable insights into 中慈助医多吉美 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 北京医方科技有限公司
- Languages
- English, Chinese
- Recent release
- 1.8.2 (1 year ago )
- Released on
- Jun 1, 2016 (8 years ago )
- Also available in
- China , Poland , South Korea , Lebanon , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Italy , Russia , Saudi Arabia , Thailand , Taiwan , United States , Vietnam , South Africa , Ecuador , Austria , Australia , Brazil , Belarus , Chile , Czechia , Dominican Republic , Algeria , Japan , Egypt , Spain , France , United Kingdom , Greece , Israel , India , Argentina
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.